EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA‐Based Single and Combined Biomarkers

Long-Bin Jeng, Wen-Ling Chan, Chiao-Fang Teng iD

Canadian Journal of Gastroenterology and Hepatology · 2026-01 · 2026 (1)

DOI: 10.1155/cjgh/1491679 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, online erschienen am 28.06.2026. Verfasst von Long-Bin Jeng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplantation Center, China Medical University Hospital, Taichung, 404, Taiwan, cmu.edu.tw. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor, MicroRNAs. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although there are various treatment modalities available for hepatocellular carcinoma (HCC), HCC is still among the most common causes of cancer‐related death globally. Identifying independent biomarkers of poor prognosis in HCC patients remains a critical goal to allow timely intervention and ameliorate patient survival. MicroRNAs (miRNAs), the most widely investigated small noncoding RNAs to date, play a crucial role in regulating the initiation and progression of HCC. The expression of numerous miRNAs is altered in tumor tissues and blood specimens of HCC patients, underscoring their potential as promising prognostic biomarkers. This review offers an exhaustive overview of the current literature examining tissue‐ and circulation‐derived miRNAs as single or combined independent prognostic biomarkers in HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBiomarkers, TumorMicroRNAsHumansPrognosis

Stichwörter der Autor:innen

combinedhepatocellular carcinomaindependent prognostic biomarkermicroRNAsingle

Substanzen

Biomarkers, TumorMicroRNAs

Autor:innen und Institutionen

  • Organ Transplantation Center, China Medical University Hospital, Taichung, 404, Taiwan, cmu.edu.tw.
  • Department of Surgery, China Medical University Hospital, Taichung, 404, Taiwan, cmu.edu.tw.
  • Cell Therapy Center, China Medical University Hospital, Taichung, 404, Taiwan, cmu.edu.tw.
  • School of Medicine, China Medical University, Taichung, 404, Taiwan, cmu.edu.tw.
  • Bioinformatics and Medical Engineering, College of Medical and Health Science, Asia University, Taichung, 413, Taiwan, asia.edu.tw.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 404, Taiwan, cmu.edu.cn.

ORCID-Profile: Chiao-Fang Teng

Förderung

  • China Medical University

Zitieren

APA

Jeng, L. B., Chan, W. L., & Teng, C. F. (2026). Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA‐Based Single and Combined Biomarkers. Canadian Journal of Gastroenterology and Hepatology, 2026(1). https://doi.org/10.1155/cjgh/1491679

Vancouver

Jeng LB, Chan WL, Teng CF. Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA‐Based Single and Combined Biomarkers. Canadian Journal of Gastroenterology and Hepatology. 2026;2026(1). doi:10.1155/cjgh/1491679

BibTeX
@article{Jeng2026,
  author = {Jeng, Long-Bin and Chan, Wen-Ling and Teng, Chiao-Fang},
  title = {Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA‐Based Single and Combined Biomarkers},
  journal = {Canadian Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/cjgh/1491679}
}
Kostenlos starten →